ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Utility of Donor Derived Cell-Free DNA in Liver Transplantation

A. Zarrinpar, D. Lewis, C. Warren, S. Duarte

Surgery, University of Florida, Gainesville, FL

Meeting: 2022 American Transplant Congress

Abstract number: 1557

Keywords: Liver transplantation, Monitoring, Rejection

Topic: Basic Science » Basic Clinical Science » 17 - Biomarkers: Clinical Outcomes

Session Information

Session Name: Biomarkers: Clinical Outcomes

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: As a non-invasive measure of allograft injury, quantifying the fraction of donor-derived cell-free DNA (dd-cfDNA) has proven to be useful technique in kidney transplantation. Its utility in liver transplantation, however, remains unproven. Specifically, whether the dd-cfDNA fraction adds any additional information on allograft status over the standard liver function tests (LFTs) is unclear.

*Methods: We evaluated the correlation of dd-cfDNA with standard postoperative LFTs after liver transplantation in a prospectively collected cohort of patients at the University of Florida. Adult recipients of orthotopic whole liver grafts were enrolled under an IRB approved protocol. Dd-cfDNA was measured in up to fifteen plasma samples obtained at the same time as standard-of-care LFT measurements between two weeks and one year after transplantation. The study included patients with stable liver function, as well as patients being evaluated for rejection or infection. 38 patients were enrolled and 112 specimens were tested for dd-cfDNA fraction.

*Results: In 28 samples with LFTs all within normal limits, dd-cfDNA fractions were below 10%. Conversely, all samples with dd-cfDNA fraction greater than 10% had either elevated alanine aminotransferase (ALT) or alkaline phosphatase. There was a close correlation between dd-cfDNA % and 1/sqrt(AST) or 1/sqrt(ALT) (R2 = 0.63 and 0.68, respectively). When examined on an individual patient basis, this correlation was tighter with few exceptions.

*Conclusions: Given these findings, dd-cfDNA quantification does not appear to provide additional sensitivity over standard LFTs for routine monitoring of post-transplant allograft injury in liver transplantation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Zarrinpar A, Lewis D, Warren C, Duarte S. Utility of Donor Derived Cell-Free DNA in Liver Transplantation [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/utility-of-donor-derived-cell-free-dna-in-liver-transplantation/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences